Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ENTPD1 contributors: mct - updated : 05-12-2016
HGNC name ectonucleoside triphosphate diphosphohydrolase 1
HGNC id 3363
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • basic leucine zipper (bZIP) like structure
  • four apyrase conserved regions in N terminal region (ACR)
  • site of binding to RANBP9
  • conjugated GlycoP
    HOMOLOGY
    interspecies homolog to rattus brain E type ecto ATPase
    Homologene
    FAMILY
  • GDA1/CD39 NTPase family
  • ectonucleoside triphosphate diphosphohydrolase (ENTPDase) family
  • CATEGORY adhesion , enzyme , transcription factor , antigen
    SUBCELLULAR LOCALIZATION     plasma membrane
    text
  • localized in caveolae, which are plasma membrane invaginations with distinct lipid composition, similar to dynamic lipid microdomains, called rafts
  • expressed at the sympathetic neuromuscular junction, where ATP is co-released with norepinephrine
  • basic FUNCTION
  • ectoenzyme that degrades ATP to AMP
  • modulating P2 receptor signaling by controlling nucleotides concentrations at the cell surface
  • ecto-nucleotidase influencing P2 receptor activation to regulate vascular and immune cell adhesion and signaling events pivotal in inflammation
  • regulates purinergic receptor signaling by controlling the levels of extracellular nucleotides
  • having a role in thromboregulation (through its localization in cholesterol-rich domains of the membrane)
  • by hydrolyzing ATP and ADP to AMP, regulates ligand availability to a large family of P2 (purinergic) receptors (Friedman 2007)
  • vascular protective factor in diabetic nephropathy that modulates glomerular inflammation and thromboregulation (Friedman 2007)
  • controls IL8 production by human neutrophils via the regulation of P2Y(2) activation
  • has anti-inflammatory properties as it hydrolyzes proinflammatory extracellular ATP, generates anti-inflammatory adenosine, and also protects regulatory T cells from ATP-induced cell death
  • is an integral component of regulatory T cells (Treg), which are central to immunological tolerance and maintenance of normal pregnancy
  • cellular homeostasis and fibrotic response involve the integration of signaling that is pro-fibrotic by ATP and anti-fibrotic by adenosine and that is regulated by ENTPD1 and ENTPD2
  • is a key "molecular switch" that allows macrophages to self-limit their activation state
  • extracellular adenosine, generated in tandem by ecto-enzymes ENTPD1 and NT5E, promotes dermal fibrogenesis
  • ENTPD1 modulates local renin release and thus, RAS activation, ultimately exerting a cardioprotective effect
  • expression of ENTPD1 in Tregs is primarily genetically driven, and this may determine interindividual differences in the control of inflammatory responses
  • marker of regulatory immune cells and catalyzes extracellular hydrolysis of nucleotides to generate AMP and, in tandem with NT5E, adenosine
  • ENTPD1, NT5E are two ectonucleotidases that cooperate in the generation of extracellular adenosine through ATP hydrolysis, thus tilting the balance towards immunosuppressive microenvironments
  • nucleotide-converting ectoenzymes, such as ENTPD1, ENTPD7, and ENPP3, inhibit ATP-dependent immune responses by hydrolyzing ATP, thereby contributing to immune response regulation
  • catalyzes the phosphohydrolysis of extracellular ATP (eATP) and ADP (eADP) released under conditions of inflammatory stress and cell injury
  • plays a dominant role in the purinergic regulation of inflammation and the immune response because its expression is influenced by genetic and environmental factors
  • CELLULAR PROCESS cell life, cell death/apoptosis
    nucleotide, transcription
    PHYSIOLOGICAL PROCESS coagulation/hemostasis , immunity/defense
    text prevention of platelet aggregation
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • associations with RANBP9 having the potential to regulate NTPDase catalytic activity( this intermolecular interaction may have important implications for the regulation of extracellular nucleotide-mediated signaling)
  • is a negative regulator of P2RX7-mediated inflammatory cell death in mast cells
  • KLRB1 and ENTPD1 have direct interactions that are further linked with acid sphingomyelinase (ASM)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) SPG64
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    correlated with better long-term survival after tumor resection in patients with pancreatic cancer
    tumoral     --over  
    in malignant epithelial cells of human rectal adenocarcinoma
    constitutional     --low  
    decreased in the late-onset preeclamptic (PE) placenta
    Susceptibility
    Variant & Polymorphism
    Candidate gene marker of a Treg subset likely involved in the control of the inflammatory autoimmune disease
    Marker
  • dysregulated levels of ENTPD1 genes may be involved in sepsis pathophysiology and may be utilized as potential diagnostic biomarker
  • ENTPD1 may act as potential markers for the clinical diagnosis of PE
  • Therapy target
    SystemTypeDisorderPubmed
    dermatologyskin 
    biochemical or biological inhibitors of ENTPD1 and/or NT5E may hold promise in the treatment of dermal fibrosis in diseases such as scleroderma
    cancerhemopathy 
    may serve as a future target for the development of novel therapies with immune-modulating antitumor agents in chronic lymphocytic leukemia
    reproductionpregnancyplacenta
    CD39 is a target for the clinical treatment of PE
    ANIMAL & CELL MODELS
  • Entpd1 null mice exhibit decreased synaptic efficacy, presumably due to desensitization P2X1 receptors
  • in rat models of DNA damage, inhibiting Entpd1-driven ATP hydrolysis with POM-1 protected the heart and lung tissues against chemically induced DNA damage